eFFECTOR Therapeutics, Inc.
USD0.00
+0.00 (+200.00%)
CEO
Davide Ruggero
IPO Date
2021-03-01
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.01
Market Cap
$0.00B
Volume
0.00M
| 800 |
| $1.38 |
| 13 Jun 2024 | Ehrlich Christopher B | director | A-Award | Acquired | 800 | $1.38 |
| 13 Jun 2024 | Loewy Caroline M | director | A-Award | Acquired | 800 | $1.38 |
| 17 May 2024 | Byrnes Michael | Chief Financial Officer | A-Award | Acquired | 1,387 | $1.68 |
| 17 May 2024 | WORLAND STEPHEN T | director, officer: Chief Executive Officer | A-Award | Acquired | 1,806 | $1.68 |
| 21 Feb 2024 | Gallagher Brian M. Jr. | director | A-Award | Acquired | 2,000 | $11.32 |
| 21 Feb 2024 | Byrnes Michael | Chief Financial Officer | A-Award | Acquired | 40,000 | $11.32 |
| 21 Feb 2024 | Klencke Barbara | director | A-Award | Acquired | 2,000 | $11.32 |
| 21 Feb 2024 | WORLAND STEPHEN T | director, officer: Chief Executive Officer | A-Award | Acquired | 80,000 | $11.32 |